NEW YORK -- Two suppliers have launched innovative line extensions in the anti-itch category, which many retailers stock in their first aid departments.
B.F. Ascher & Co. has introduced dual-acting Itch-X in a spray, while Alva/Amco Pharmacal Cos. has rolled out Psoriasin topical psoriasis medication in a liquid for the scalp.
Debuts of effective products are welcome at drug stores, which generated over half of the $307 million in sales of anti-itch treatments recorded in the 12 months ended March 29, according to Information Resources Inc. (IRI) While private label products led the market with volume of $47.9 million, their sales were down 1.8%.
Standout performers among branded products included No. 3 Cortaid from Pharmacia & Upjohn Inc. (whose volume was up 12.4%), Combe Inc.'s sixth-place Lanacane (up 14.1%) and No. 7 Lotrimin from Schering-Plough Corp. (up 36%).
Data on sales growth for Chattem Inc.'s fifth-place Gold Bond was not available from IRI, but the cream per- forms commendably at Kerr Drug, says category …
No comments:
Post a Comment